Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by MustangSalleyon Jan 10, 2022 11:13am
246 Views
Post# 34299880

RE:The NEWS is good!

RE:The NEWS is good!

rixpix wrote: Click on news on top for the article.

 

Ripper,

What happened ?  Your sheer arrogance in highlighting $2 sell mark has come and bit you hard . Karma Ripper . Karma ripper .

@Steadfast.   This has all the signs of institutional shorting by Canancoord . Management has made a deal with the devil and they are taking the legs out right underneath .

@Bioteck is right free warrants are an insurance policy . 25% return on a short is not too shabby .

Spillup should fire Doug Loe . He is like a wolf in the henhouse but Spillup is too stupid to understand how capital markets work.

News was good . The fact it did not hold $2 is disappointing . Steadfast this is a repeat of last year for sure .

Canacorrd will cover at $1.50 their new base imo .


Ms Mustang Sally 

<< Previous
Bullboard Posts
Next >>